BioSpace News Archive

Avadel Pharmaceuticals Announces Proposed Exchangeable Senior Notes Offering

In connection with the Offering, the Issuer expects to grant the initial purchasers of the Notes a 30-day option to purchase up to an additional $18,750,000 principal amount of Notes.

February 14, 2018
·
7 min read
Business

Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on February 27

The live audio webcast may be accessed through the “Events & Presentations” page in the “Investors” section of the company’s website.

February 14, 2018
·
1 min read
Drug Development

Incysus Presents Positive Data on Drug-Resistant Immunotherapy for Glioblastoma at AACR CNS Immunotherapy Conference

Dr. Lamb, presented new data on the Company’s adoptive cell therapy program for glioblastoma.

February 14, 2018
·
3 min read
Drug Development

The New England Journal of Medicine Publishes Biogen’s SPINRAZA (nusinersen) Phase III Study Results in Individuals with Later-Onset Spinal Muscular Atrophy

Data from the other endpoints analyzed, including attainment of new motor milestones and upper limb motor function, were consistently in favor of individuals who received treatment and were considered clinically significant.

February 14, 2018
·
15 min read
Business

DelMar Pharma Announces Second Quarter Fiscal Year 2018 Financial Results

DelMar Pharma announced its financial results for the second quarter ended December 31, 2017.

February 14, 2018
·
12 min read